We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Biogen Inc | LSE:0R1B | London | Ordinary Share | BIOGEN INC ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.00 | 0.00% | 277.67 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
1,652 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 9.84B | 1.16B | 8.0132 | 26.07 | 30.27B |
Date | Time | Source | Headline |
---|---|---|---|
06/3/2024 | 12:30 | UKREG | New Biomarker Data Add Further Evidence Supporting the Potential Benefit of.. |
04/3/2024 | 21:15 | UKREG | Biogen Highlights New Data at the International Conference on Alzheimer’s.. |
23/2/2024 | 12:00 | UKREG | Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form.. |
12/2/2024 | 21:06 | UKREG | Biogen Received European Commission Approval for SKYCLARYS®.. |
31/1/2024 | 12:30 | UKREG | Biogen to Realign Resources for Alzheimer's Disease Franchise |
06/8/2023 | 17:07 | ALNC | CORRECT: Biogens, Sage Therapeutics postpartum depression drug okayed |
06/8/2023 | 14:17 | ALNC | Biogens, Sage Therapeutics postpartum depression treatment approved |
09/6/2023 | 12:12 | ALNC | *Nasdaq halts trading of Biogen stock |
1 Year Biogen Chart |
Intraday Biogen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions